19 MAY 2011
A record US$ 3 billion was disbursed in 2010, according to new report
GENEVA –The Global Fund to Fight AIDS, Tuberculosis and Malaria disbursed a record US$ 3 billion in 2010. This helped boost the number of people on antiretroviral therapy in Global Fund-supported programs to an estimated 3 million; increase the number of people treated for multidrug resistant TB by half; and contribute to a big expansion in malaria treatment and prevention.
These remarkable results are part of “Making a Difference”, a new report launched on 19 May in Paris which shows in detail how the Global Fund has helped to save 6.5 million lives between 2002 and 2010.
“We have made immense progress in the fight against the three epidemics, as this report shows”, said Professor Michel Kazatchkine, Executive Director of the Global Fund. “But the challenges ahead are huge. We need to sustain the momentum, we need greater efficiency and we need continued support from our donors to ensure that these gains are not lost.”
Globally, malaria programs saw the biggest progress. The number of insecticide-treated nets distributed between 2002 -- the year in which the Global Fund started operating -- and 2010, rose to 160 million from 104 million a year earlier. Global Fund programs have also enabled the treatment of 170 million cases of malaria over the same period.
The cumulative number of cases of tuberculosis detected and treated by the end of 2010 increased by 29 per cent from 2009. The cumulative number of multidrug-resistant tuberculosis cases treated rose by almost 50 per cent from the previous year in 2010 “when many countries redoubled their efforts to counter this major threat to global TB control”, according to the report.
Global Fund programs provided antiretroviral drugs to 1 million pregnant women living with HIV in order to prevent transmission of the virus to their children.
In 2010, the Global Fund investment in measures to strengthen health systems reached an estimated US$ 7.8 billion in approved funding. The money has been directed to overcome bottlenecks in the delivery of lifesaving services and to improve the effectiveness of HIV, TB and malaria programs.
The Global Fund provided 21 per cent of international public HIV funding and 65 per cent of international TB funding for the 22 countries with the highest burden of the disease and of international malaria funding in 2009, the latest year for which data this available.
Cost-saving measures implemented by the Global Fund between 2005 and the end of 2010 saved US$ 1.2 billion. This money was reallocated to other programs to help maximize their impact.
Emerging trends
The report also assesses prospects in the five year run-up to the 2015 Millennium Development Goal of bringing AIDS, tuberculosis and malaria under control.
By 2015, Global Fund-supported programs are expected to provide 6 million people with antiretroviral treatment – doubling the number of people assisted today.
In the fight against tuberculosis, the Global Fund share of spending in first-line tuberculosis treatment may fall, as more funds are directed to the treatment of multidrug-resistant tuberculosis.
On malaria, the life-span of long-lasting insecticidal nets delivered in 2007, 2008 and 2009 is approaching the end, and they will need to be replaced. The report warns that failure to do so could lead to a resurgence in the number of malaria cases and deaths.
In 2010 the Global Fund successfully implemented a new policy which aims to reduce the number of existing grants by consolidating them into single streams of funding. This is intended to simplify management of grants for recipient countries. The Secretariat created 49 new single funding streams, reducing the total number of grants by nearly 10 per cent. By the end of 2011, one-third of the entire grant portfolio is expected to be brought under the new approach.
A record US$ 3 billion was disbursed in 2010, according to new report
GENEVA –The Global Fund to Fight AIDS, Tuberculosis and Malaria disbursed a record US$ 3 billion in 2010. This helped boost the number of people on antiretroviral therapy in Global Fund-supported programs to an estimated 3 million; increase the number of people treated for multidrug resistant TB by half; and contribute to a big expansion in malaria treatment and prevention.
These remarkable results are part of “Making a Difference”, a new report launched on 19 May in Paris which shows in detail how the Global Fund has helped to save 6.5 million lives between 2002 and 2010.
“We have made immense progress in the fight against the three epidemics, as this report shows”, said Professor Michel Kazatchkine, Executive Director of the Global Fund. “But the challenges ahead are huge. We need to sustain the momentum, we need greater efficiency and we need continued support from our donors to ensure that these gains are not lost.”
Globally, malaria programs saw the biggest progress. The number of insecticide-treated nets distributed between 2002 -- the year in which the Global Fund started operating -- and 2010, rose to 160 million from 104 million a year earlier. Global Fund programs have also enabled the treatment of 170 million cases of malaria over the same period.
The cumulative number of cases of tuberculosis detected and treated by the end of 2010 increased by 29 per cent from 2009. The cumulative number of multidrug-resistant tuberculosis cases treated rose by almost 50 per cent from the previous year in 2010 “when many countries redoubled their efforts to counter this major threat to global TB control”, according to the report.
Global Fund programs provided antiretroviral drugs to 1 million pregnant women living with HIV in order to prevent transmission of the virus to their children.
In 2010, the Global Fund investment in measures to strengthen health systems reached an estimated US$ 7.8 billion in approved funding. The money has been directed to overcome bottlenecks in the delivery of lifesaving services and to improve the effectiveness of HIV, TB and malaria programs.
The Global Fund provided 21 per cent of international public HIV funding and 65 per cent of international TB funding for the 22 countries with the highest burden of the disease and of international malaria funding in 2009, the latest year for which data this available.
Cost-saving measures implemented by the Global Fund between 2005 and the end of 2010 saved US$ 1.2 billion. This money was reallocated to other programs to help maximize their impact.
Emerging trends
The report also assesses prospects in the five year run-up to the 2015 Millennium Development Goal of bringing AIDS, tuberculosis and malaria under control.
By 2015, Global Fund-supported programs are expected to provide 6 million people with antiretroviral treatment – doubling the number of people assisted today.
In the fight against tuberculosis, the Global Fund share of spending in first-line tuberculosis treatment may fall, as more funds are directed to the treatment of multidrug-resistant tuberculosis.
On malaria, the life-span of long-lasting insecticidal nets delivered in 2007, 2008 and 2009 is approaching the end, and they will need to be replaced. The report warns that failure to do so could lead to a resurgence in the number of malaria cases and deaths.
In 2010 the Global Fund successfully implemented a new policy which aims to reduce the number of existing grants by consolidating them into single streams of funding. This is intended to simplify management of grants for recipient countries. The Secretariat created 49 new single funding streams, reducing the total number of grants by nearly 10 per cent. By the end of 2011, one-third of the entire grant portfolio is expected to be brought under the new approach.
No comments:
Post a Comment